Literature DB >> 26495450

[Rhinosinusitis in cystic fibrosis].

J G Mainz1, A Gerber, C Arnold, J Baumann, I Baumann, A Koitschev.   

Abstract

In cystic fibrosis (CF) mucociliary clearance of the entire respiratory system is impaired. This allows pathogens, such as Pseudomonas aeruginosa to persist and proliferate, which by progressive pulmonary destruction causes 90 % of premature deaths due to this inherited disease. The dramatic improvement in life expectation of patients due to intensive therapy has resulted in the inevitable but variably expressed sinonasal involvement coming into the clinical and scientific focus. Thereby, almost all CF patients reveal sinonasal pathology and many suffer from chronic rhinosinusitis. Recently, the sinonasal niche has been recognized as a site of initial and persistent colonization by pathogens. This article presents the pathophysiological background of this multiorgan disease as well as general diagnostic and therapeutic standards. The focus of this article is on sinonasal involvement and conservative and surgical options for treatment. Prevention of pathogen acquisition is an essential issue in the otorhinolaryngological treatment of CF patients.

Entities:  

Mesh:

Year:  2015        PMID: 26495450     DOI: 10.1007/s00106-015-0069-7

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  29 in total

1.  Deposition of aerosolized particles in the maxillary sinuses before and after endoscopic sinus surgery.

Authors:  Michele B St Martin; Cory J Hitzman; Timothy S Wiedmann; Frank L Rimell
Journal:  Am J Rhinol       Date:  2007 Mar-Apr

2.  Management of chronic rhinosinusitis in CF.

Authors:  Jochen G Mainz; Assen Koitschev
Journal:  J Cyst Fibros       Date:  2009-06       Impact factor: 5.482

Review 3.  Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management.

Authors:  C Gysin; G A Alothman; B C Papsin
Journal:  Pediatr Pulmonol       Date:  2000-12

4.  Effect of endoscopic sinus surgery on pulmonary function and microbial pathogens in a pediatric population with cystic fibrosis.

Authors:  Alexander J Osborn; Randy Leung; Felix Ratjen; Adrian L James
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2011-06

Review 5.  Pathogenesis and management of nasal polyposis in cystic fibrosis.

Authors:  Jochen G Mainz; Assen Koitschev
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

6.  Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis.

Authors:  J G Mainz; L Naehrlich; M Schien; M Käding; I Schiller; S Mayr; G Schneider; B Wiedemann; L Wiehlmann; N Cramer; W Pfister; B C Kahl; J F Beck; B Tümmler
Journal:  Thorax       Date:  2009-03-11       Impact factor: 9.139

7.  Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.

Authors:  Kasper Aanæs
Journal:  J Cyst Fibros       Date:  2013-09       Impact factor: 5.482

8.  Sinonasal inhalation of dornase alfa administered by vibrating aerosol to cystic fibrosis patients: a double-blind placebo-controlled cross-over trial.

Authors:  Jochen G Mainz; Claudia Schien; Isabella Schiller; Katja Schädlich; Assen Koitschev; Christiane Koitschev; Joachim Riethmüller; Uta Graepler-Mainka; Bärbel Wiedemann; James F Beck
Journal:  J Cyst Fibros       Date:  2014-03-01       Impact factor: 5.482

9.  Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.

Authors:  Eitan Kerem; Michael W Konstan; Kris De Boeck; Frank J Accurso; Isabelle Sermet-Gaudelus; Michael Wilschanski; J Stuart Elborn; Paola Melotti; Inez Bronsveld; Isabelle Fajac; Anne Malfroot; Daniel B Rosenbluth; Patricia A Walker; Susanna A McColley; Christiane Knoop; Serena Quattrucci; Ernst Rietschel; Pamela L Zeitlin; Jay Barth; Gary L Elfring; Ellen M Welch; Arthur Branstrom; Robert J Spiegel; Stuart W Peltz; Temitayo Ajayi; Steven M Rowe
Journal:  Lancet Respir Med       Date:  2014-05-15       Impact factor: 30.700

10.  Pseudomonas aeruginosa Acquisition in Cystic Fibrosis Patients in Context of Otorhinolaryngological Surgery or Dentist Attendance: Case Series and Discussion of Preventive Concepts.

Authors:  Jochen G Mainz; Andrea Gerber; Michael Lorenz; Ruth Michl; Julia Hentschel; Anika Nader; James F Beck; Mathias W Pletz; Andreas H Mueller
Journal:  Case Rep Infect Dis       Date:  2015-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.